insights_auto
Why is BOT up 18.75%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.0095
arrow_upward
+18.75%(+0.0015) 1D
Nov 17, 3:29:06 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
23.62M
Avg. vol.
10.87M
Volume
8.84M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
23.62M
Avg. vol.
10.87M
Volume
8.84M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Yahoo Finance
·
43 minutes ago
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
8 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
13 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
4 hours ago
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com